Immunomodulation, IL-1 Inhibition, and Postoperative Incisional Pain
Status:
Terminated
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that perioperative administration of anakinra will reduce
incisional pain by lowering the concentration of inflammatory mediators in surgical wounds.
This knowledge is important because it suggests a new, previously unexplored pharmacological
target for the control of postoperative incisional pain.